Authors:
D'Cruz, CM
Gunther, EJ
Boxer, RB
Hartman, JL
Sintasath, L
Moody, SE
Cox, JD
Ha, SI
Belka, GK
Golant, A
Cardiff, RD
Chodosh, LA
Citation: Cm. D'Cruz et al., c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations, NAT MED, 7(2), 2001, pp. 235-239
Authors:
Hosokawa, Y
Papanikolaou, A
Cardiff, RD
Yoshimoto, K
Bernstein, M
Wang, TC
Schmidt, EV
Arnold, A
Citation: Y. Hosokawa et al., In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53, TRANSGEN RE, 10(5), 2001, pp. 471-478
Authors:
White, DE
Cardiff, RD
Dedhar, S
Muller, WJ
Citation: De. White et al., Mammary epithelial-specific expression of the integrin linked kinase (ILK)results in the induction of mammary gland hyperplasias and tumors in transgenic mice, ONCOGENE, 20(48), 2001, pp. 7064-7072
Citation: J. Hutchinson et al., Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression, MOL CELL B, 21(6), 2001, pp. 2203-2212
Authors:
Dankort, D
Maslikowski, B
Warner, N
Kanno, N
Kim, H
Wang, ZX
Moran, MF
Oshima, RG
Cardiff, RD
Muller, WJ
Citation: D. Dankort et al., Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: Implications for human breast cancer, MOL CELL B, 21(5), 2001, pp. 1540-1551
Authors:
Zhu, JW
Field, SJ
Gore, L
Thompson, M
Yang, HD
Fujiwara, Y
Cardiff, RD
Greenberg, M
Orkin, SH
DeGregori, J
Citation: Jw. Zhu et al., E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis, MOL CELL B, 21(24), 2001, pp. 8547-8564
Citation: Ar. Moser et al., Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(Min)/+ mice, CANCER RES, 61(8), 2001, pp. 3480-3485
Citation: M. Lebel et al., Tumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicase, CANCER RES, 61(5), 2001, pp. 1816-1819
Authors:
Zahnow, CA
Cardiff, RD
Laucirica, R
Medina, D
Rosen, JM
Citation: Ca. Zahnow et al., A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation, CANCER RES, 61(1), 2001, pp. 261-269
Citation: Rd. Cardiff et al., Mammary cancer in humans and mice: A tutorial for comparative pathology. The CD-ROM, J MAMMARY G, 5(2), 2000, pp. 243-244
Authors:
Cardiff, RD
Anver, MR
Gusterson, BA
Hennighausen, L
Jensen, RA
Merino, MJ
Rehm, S
Russo, J
Tavassoli, FA
Wakefield, LM
Ward, JM
Green, JE
Citation: Rd. Cardiff et al., The mammary pathology of genetically engineered mice: the consensus reportand recommendations from the Annapolis meeting, ONCOGENE, 19(8), 2000, pp. 968-988
Citation: G. Shyamala et al., Impact of progesterone receptor on cell-fate decisions during mammary gland development, P NAS US, 97(7), 2000, pp. 3044-3049
Authors:
Andrechek, ER
Hardy, WR
Siegel, PM
Rudnicki, MA
Cardiff, RD
Muller, WJ
Citation: Er. Andrechek et al., Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis, P NAS US, 97(7), 2000, pp. 3444-3449
Authors:
Rauh, MJ
Blackmore, V
Andrechek, ER
Tortorice, CG
Daly, R
Lai, VKM
Pawson, T
Cardiff, RD
Siegel, PM
Muller, WJ
Citation: Mj. Rauh et al., Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein, MOL CELL B, 19(12), 1999, pp. 8169-8179
Authors:
Siegel, PM
Ryan, ED
Cardiff, RD
Muller, WJ
Citation: Pm. Siegel et al., Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer, EMBO J, 18(8), 1999, pp. 2149-2164
Authors:
Neznanov, N
Man, AK
Yamamoto, H
Hauser, CA
Cardiff, RD
Oshima, RG
Citation: N. Neznanov et al., A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice, CANCER RES, 59(17), 1999, pp. 4242-4246